Table 2.
Correlation between MYO5A expression and the clinicopathological features of patients with LSCC
| Parameters | Patients n (%) | MYO5A level | P-value |
|---|---|---|---|
| Total | 132 | ||
| Sex | 0.883 | ||
| Male | 114 (86.4) | 64.60±15.22 | |
| Female | 18 (13.6) | 64.03±15.52 | |
| Age (years) | 0.864 | ||
| ≥60 | 84 (63.6) | 64.35±15.21 | |
| <60 | 48 (36.4) | 64.83±15.35 | |
| Primary site | 0.952 | ||
| Glottic | 76 (57.6) | 64.46±15.53 | |
| Supraglottic | 56 (42.4) | 64.62±14.89 | |
| T stage | 0.003 | ||
| T2 | 51 (38.6) | 59.60±14.40 | |
| T3 T4 | 81 (61.4) | 67.63±14.96 | |
| Differentiation | 0.713 | ||
| High | 85 (64.4) | 64.78±14.95 | |
| Moderate and low | 47 (35.6) | 63.91±14.09 | |
| Neck lymph node metastasis | |||
| N+ | 61 (46.2) | 73.02±12.39 | |
| N− | 71 (53.8) | 57.23±13.57 | |
| Perinodal invasion | 0.037 | ||
| + | 21 (45.7) | 69.23±18.81 | |
| − | 25 (54.3) | 60.17±16.79 | |
| Lymphovascular and perineural invasion | 0.274 | ||
| + | 13 (28.3) | 66.39±16.51 | |
| − | 33 (71.7) | 63.11±15.88 |
Note: The data is presented as mean ± SD.
Abbreviation: LSCC, laryngeal squamous cell carcinoma.